Rellahan B L, Jones L A, Kruisbeek A M, Fry A M, Matis L A
Division of Cytokine Biology, Food and Drug Administration, National Institutes of Health, Bethesda, Maryland 20892.
J Exp Med. 1990 Oct 1;172(4):1091-100. doi: 10.1084/jem.172.4.1091.
We have developed a model of peripheral in vivo T cell tolerance that is induced by administration of the protein superantigen staphylococcal enterotoxin B (SEB). Rather than activating V beta 8+ T cells, in vivo administration of SEB induced in them a profound state of anergy. This was shown by their failure to proliferate to subsequent in vitro restimulation with SEB or to anti-V beta 8 antibodies. This unresponsiveness was V beta 8 specific since T cells from SEB-immunized mice responded normally to other antigens. 8 d after SEB administration, there was no reduction in the number of V beta 8+ T cells or in the intensity of V beta 8 T cell receptor (TCR) expression. Although a portion of the V beta 8+ T cells from SEB-primed mice were able to express interleukin 2 receptors (IL-2Rs), they failed to proliferate in response to exogenous IL-2, indicating they were defective in their IL-2 responsiveness. 2-4 wk after SEB administration, there was a reduction of approximately 50% in the number of V beta 8+ cells in immunized compared with control animals. There was, however, no reduction in the level of TCR expression on the remaining V beta 8+ cells. These data demonstrate that proteins that activate T cells in vitro in a V beta-specific manner can induce a state of anergy in peripheral T cells in vivo and may possibly further mediate clonal deletion in a portion of the tolerized cells.
我们构建了一种外周体内T细胞耐受模型,该模型由蛋白质超抗原葡萄球菌肠毒素B(SEB)的给药诱导产生。与激活Vβ8 + T细胞不同,SEB的体内给药在这些细胞中诱导出一种深度无反应状态。这表现为它们无法对随后用SEB或抗Vβ8抗体进行的体外再刺激进行增殖。这种无反应性是Vβ8特异性的,因为来自SEB免疫小鼠的T细胞对其他抗原反应正常。给予SEB 8天后,Vβ8 + T细胞的数量或Vβ8 T细胞受体(TCR)表达的强度没有降低。虽然来自SEB预致敏小鼠的一部分Vβ8 + T细胞能够表达白细胞介素2受体(IL-2Rs),但它们对外源性IL-2无增殖反应,表明它们的IL-2反应性存在缺陷。给予SEB 2 - 4周后,与对照动物相比,免疫动物中Vβ8 +细胞的数量减少了约50%。然而,剩余Vβ8 +细胞上的TCR表达水平没有降低。这些数据表明,在体外以Vβ特异性方式激活T细胞的蛋白质可以在体内诱导外周T细胞产生无反应状态,并可能进一步介导一部分耐受细胞的克隆清除。